Alniche Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.01 Cr
as on 09-12-2024
- Paid Up Capital ₹ 0.13 M
as on 09-12-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 75.39 Cr
as on 09-12-2024
- Satisfied Charges ₹ 37.28 Cr
as on 09-12-2024
- Revenue 3.97%
(FY 2022)
- Profit -869.77%
(FY 2022)
- Ebitda -880.19%
(FY 2022)
- Net Worth -73.42%
(FY 2022)
- Total Assets -25.44%
(FY 2022)
About Alniche Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.01 Cr and a paid-up capital of Rs 0.13 M.
The company currently has active open charges totaling ₹75.39 Cr. The company has closed loans amounting to ₹37.28 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mehak Arora, Tirunelveli Devarajan, Karan Arora, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909DL2012PTC244770
- Company No.
244770
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alniche Lifesciences Private Limited offer?
Alniche Lifesciences Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs.
Who are the key members and board of directors at Alniche Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehak Arora  | Director | 01-Dec-2015 | Current |
| Tirunelveli Devarajan | Director | 31-May-2018 | Current |
| Karan Arora | Director | 09-Nov-2012 | Current |
| Girish Arora | Director | 09-Nov-2012 | Current |
Financial Performance and Corporate Structure Insights of Alniche Lifesciences.
Alniche Lifesciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.97% increase. The company also saw a substantial fall in profitability, with a 869.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 73.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alniche Lifesciences?
In 2022, Alniche Lifesciences had a promoter holding of 99.90% and a public holding of 0.10%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Malladi Drugs And Pharmaceuticals LimitedActive 44 years 4 monthsTirunelveli Devarajan is a mutual person
Effikasia Lifesciences Private LimitedActive 4 years 24 daysKaran Arora and Girish Arora are mutual person
Ankura Medical & Research Centre Private LimitedActive 13 years 7 daysTirunelveli Devarajan is a mutual person
Phasorz Technologies Private LimitedActive 11 years 4 monthsTirunelveli Devarajan is a mutual person
Sandor Life Sciences Private LimitedActive 20 years 5 monthsTirunelveli Devarajan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Feb 2024 | ₹3.31 M | Open |
Hdfc Bank Limited Creation Date: 26 Feb 2024 | ₹6.31 M | Open |
Axis Bank Limited Creation Date: 24 Sep 2021 | ₹2.05 M | Open |
How Many Employees Work at Alniche Lifesciences?
Alniche Lifesciences has a workforce of 730 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alniche Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alniche Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
